Analyst Matt Miksic works at BARCLAYS and is covering the the Healthcare sector with 548 price targets and ratings documented since 2012 spanning on 24 stocks. Previously, Matt Miksic worked at CREDIT SUISSE, UBS, PIPER SANDLER.
Matt Miksic's average stock forecast success ratio is 60.69% with an average time for price targets to be met of 291.88 days.
Most recent stock forecast was given on NUVA, NuVasive, Inc at 12-May-2023.
Analyst best performing recommendations are on ISRG (INTUITIVE SURGICAL, INC).
The best stock recommendation documented was for ISRG (INTUITIVE SURGICAL, INC) at 10/18/2022. The price target of $235 was fulfilled within 7 days with a profit of $41.27 (21.3%) receiving and performance score of 30.43.
Average potential price target upside
Currently, out of the existing stock ratings of Matt Miksic - 3 which are a Buy (100%)
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average time for PT to be met
Performance score
Buy
112
$8.24 (7.94%)
146
7 days ago
6/8 (75%)
$13.71 (20.86%)
441
Buy
130
$26.24 (25.29%)
123
1 months 20 days ago
0/3 (0%)
$22.14 (21.25%)
Buy
116
$12.24 (11.80%)
123
1 months 20 days ago
11/17 (64.71%)
$11.98 (11.22%)
102
Buy
117
$13.24 (12.76%)
140
2 months 8 days ago
13/15 (86.67%)
$12.49 (24.95%)
499
Buy
125
$21.24 (20.47%)
122
4 months 10 days ago
13/18 (72.22%)
$15.44 (17.89%)
243
